Are you Dr. Sica?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Page St
# Southcoa
New Bedford, MA 02740Phone+1 508-961-5919Fax+1 508-961-5916
Summary
- Dr. Roberto Sica, MD is an oncologist in New Bedford, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New York, and California. He is affiliated with Montefiore Medical Center.
Education & Training
- Steward Carney HospitalResidency, Internal Medicine, 2007 - 2010
- University of Buenos AiresClass of 1998
Certifications & Licensure
- CA State Medical License 2016 - 2026
- IL State Medical License 2014 - 2026
- MA State Medical License 2010 - 2026
- NY State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsOutcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, Riya Patel, Rama Al Hamed
Clinical Hematology International. 2023-06-01 - 3 citationsLenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B Donnellan, Jesus Berdeja
Clinical Cancer Research. 2023-01-04 - 6 citationsHigh seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.Lauren C Shapiro, Astha Thakkar, Radhika Gali, Jesus D Gonzalez-Lugo, Abdul-Hamid Bazarbachi
Leukemia & Lymphoma. 2022-10-01
Press Mentions
- Should Therapy for Hematologic Malignancies Be Modified to Mitigate Poor COVID-19 Outcomes?February 25th, 2021